Sunovion Plans September Launch For Parkinson’s 'Off' Episode Drug Kynmobi

 
• By Mandy Jackson

Kynmobi is an important approval for parent company Sumitomo Dainippon ahead of the loss of exclusivity for Latuda. Sunovion hopes to launch after COVID-19 social distancing requirements ease.

Close Up Of Senior Man Suffering With Parkinsons Diesease
Tremors, stiffness and other motor symptoms emerge during off episodes • Source: Shutterstock

More from New Products

More from Scrip